跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mag-I
首页
药物
Mag-I
Mag-I
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN
申请人: UNIV BASEL
优先权: 2014
CN
EP
US
4 件公开
MAG expression promoters
申请人: KAWASAKI MASAKAZU
优先权: 1999
CN
US
3 件公开
Glycopeptide compound as well as preparation method and application thereof
申请人: UNIV SHANDONG
优先权: 2024
CN
TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2016
CN
EP
US
9 件公开
Transfected T-cells and T-cell receptors for use in immunotherapy against cancers
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2016
CN
US
2 件公开
High-affinity antigen of autoimmune disease antibody as well as synthesis method and application of high-affinity antigen
申请人: UNIV SHANDONG
优先权: 2025
CN
药物
反馈